Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,159 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Analysis of 500 bone marrow transplants from unrelated donors (UR-BMT) facilitated by the Japan Marrow Donor Program: confirmation of UR-BMT as a standard therapy for patients with leukemia and aplastic anemia.
Kodera Y, Morishima Y, Kato S, Akiyama Y, Sao H, Matsuyama T, Kawa K, Sakamaki H, Nakagawa S, Hirabayashi N, Dohi H, Okamoto S, Hiraoka A, Gondo H, Tsuchida M, O H, Harada M, Asano S, Juji T, Sasazuki T, Takaku F. Kodera Y, et al. Among authors: okamoto s. Bone Marrow Transplant. 1999 Nov;24(9):995-1003. doi: 10.1038/sj.bmt.1702027. Bone Marrow Transplant. 1999. PMID: 10556959
Quality of life in adult patients after stem cell transplantation.
Yano K, Kanie T, Okamoto S, Kojima H, Yoshida T, Maruta I, Dohi H, Morishita Y, Ozawa K, Sao H, Sakamaki H, Hiraoka S, Imoto S, Morishima Y, Kodera Y. Yano K, et al. Among authors: okamoto s. Int J Hematol. 2000 Apr;71(3):283-9. Int J Hematol. 2000. PMID: 10846837
Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation.
Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, Kodera Y, Kanamaru A, Dohy H, Masaoka T; Japanese FK506 BMT(Bone Marrow Transplantation) Study Group. Hiraoka A, et al. Among authors: okamoto s. Bone Marrow Transplant. 2001 Jul;28(2):181-5. doi: 10.1038/sj.bmt.1703097. Bone Marrow Transplant. 2001. PMID: 11509936 Clinical Trial.
Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party.
Kataoka I, Kami M, Takahashi S, Kodera Y, Miyawaki S, Hirabayashi N, Okamoto S, Matsumoto N, Miyazaki Y, Morishita Y, Asai O, Maruta A, Yoshida T, Imamura M, Hamajima N, Matsuo K, Harada M, Mineishi S; Japan Society for Hematopoietic Cell Transplantation Working Party. Kataoka I, et al. Among authors: okamoto s. Bone Marrow Transplant. 2004 Oct;34(8):711-9. doi: 10.1038/sj.bmt.1704659. Bone Marrow Transplant. 2004. PMID: 15361916
Secondary solid tumors after allogeneic hematopoietic SCT in Japan.
Yokota A, Ozawa S, Masanori T, Akiyama H, Ohshima K, Kanda Y, Takahashi S, Mori T, Nakaseko C, Onoda M, Kishi K, Doki N, Aotsuka N, Kanamori H, Maruta A, Sakamaki H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Yokota A, et al. Among authors: okamoto s. Bone Marrow Transplant. 2012 Jan;47(1):95-100. doi: 10.1038/bmt.2011.23. Epub 2011 Feb 28. Bone Marrow Transplant. 2012. PMID: 21358690
Favorable survival after allogeneic stem cell transplantation with reduced-intensity conditioning regimens for relapsed/refractory follicular lymphoma.
Yano S, Mori T, Kanda Y, Kato J, Nakaseko C, Fujisawa S, Tomita N, Sakai R, Shono K, Saitoh T, Aotsuka N, Kobayashi N, Saito T, Takahashi S, Kanamori H, Okamoto S; Kanto Study Group for Cell Therapy (KSGCT). Yano S, et al. Among authors: okamoto s. Bone Marrow Transplant. 2015 Oct;50(10):1299-305. doi: 10.1038/bmt.2015.158. Epub 2015 Jul 13. Bone Marrow Transplant. 2015. PMID: 26168068
3,159 results